By leveraging machine learning tools, Mass General Brigham researchers measured markers of Alzheimer’s disease on portable ...
Dr Daniel Gibbs, 74, from Portland, Oregon, USA, said he first noticed he was losing his sense of smell at age 55 - and knew ...
Dr Daniel Gibbs said he first thought he could develop Alzheimer's when he lost his sense of smell at the age of 55. Now 74, ...
Bio, a controlling interest of joint venture by Scilex Holding Company with IPMC Company, a representative company of the Bio ...
Alpha Cognition Inc. (Nasdaq: ACOG) (CSE: ACOG) (“Alpha Cognition” [ACI], or the “Company”), a biopharmaceutical company developing novel therapies fo ...
Irish Independent on MSN1d
Praise from users of Sligo clinic aimed at helping those with memory lossA Memory Assessment Support Service, or ‘MASS’ team has started at the Sligo Integrated Care Programme for Older Persons ambulatory Hub at Woodhaven, Strandhill road, Sligo. The MASS team is part of ...
Globally, approximately 139 million people are expected to have Alzheimer's disease (AD) by 2050. Magnetic resonance imaging ...
Many people tell me I don’t act like I have Alzheimer’s. That’s because I don’t – yet. I have Mild Cognitive Impairment, also ...
Changes in speech patterns may indicate that mild cognitive impairment is worsening to Alzheimer's disease, according to a ...
The Loudoun Impact Fund awarded $118,000 in grants to 18 nonprofits serving Loudoun County. This year’s grants were made ...
In 2024, startups saw a notable resurgence in large-scale funding rounds. By May, over 100 startups had secured funding ...
INmune Bio recently announced over-enrollment of its AD02 Trial in Alzheimer’s Disease focused on patients with Early AD and biomarkers of elevated neuroinflammation. Top-line cognitive data from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback